John holds a BSc, MSc, and PhD in Pharmacy specializing in Biopharmaceutics and Pharmacokinetics. For the past 11 years, he has been at the helm of the Clinical Development department at Adragos Athens (formerly Lamda Laboratories). With over 15 years of experience in the Generic Drug Industry, John initiated his career in the Pharmacovigilance sector.

 In his role as the Clinical Development Leader at Adragos Athens, he is responsible for overseeing the design and execution of clinical trials. His pivotal contributions have resulted in the successful completion of over 100 bioequivalence and bioavailability studies, leading to numerous regulatory submissions.

 Furthermore, he actively participates in the development and implementation of effective clinical and regulatory strategies for a diverse range of products, with a special emphasis on Value Added Medicines.

Throughout his career, he has been extensively and actively involved in numerous meetings with major European Regulatory Agencies, including the EMA. This engagement has not only fostered robust relationships with regulatory authorities but has also led to significant contributions to the approval process.